These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6703263)

  • 1. Effect of platelet activating factor on the human nasal mucosa.
    Pipkorn U; Karlsson G; Bake B
    Allergy; 1984 Feb; 39(2):141-5. PubMed ID: 6703263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the effects of paf-acether on human nasal airways.
    Leggieri E; Tedeschi A; Lorini M; Bianco A; Miadonna A
    Allergy; 1991 Aug; 46(6):466-71. PubMed ID: 1720286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of PAF-acether metabolic pathway activation in antigen challenge of upper respiratory airways.
    Miadonna A; Tedeschi A; Arnoux B; Sala A; Zanussi C; Benveniste J
    Am Rev Respir Dis; 1989 Jul; 140(1):142-7. PubMed ID: 2546468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nasal eosinophilia induced by PAF-acether is accompanied by the release of eosinophil cationic protein.
    Tedeschi A; Milazzo N; Miadonna A
    Eur Respir J; 1994 Aug; 7(8):1445-51. PubMed ID: 7525344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of platelet activating factor on nasal hypersensitivity.
    Andersson M; Pipkorn U
    Eur J Clin Pharmacol; 1988; 35(3):231-5. PubMed ID: 3181276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophil chemotactic activity of topical PAF on the human nasal mucosa.
    Klementsson H; Andersson M
    Eur J Clin Pharmacol; 1992; 42(3):295-9. PubMed ID: 1577048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute microvascular effects of PAF-acether, as studied by intravital microscopy.
    Björk J; Smedegård G
    Eur J Pharmacol; 1983 Dec; 96(1-2):87-94. PubMed ID: 6662199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nasal neutrophilia and eosinophilia induced by challenge with platelet activating factor.
    Tedeschi A; Palumbo G; Milazzo N; Miadonna A
    J Allergy Clin Immunol; 1994 Feb; 93(2):526-33. PubMed ID: 8120279
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous and pulmonary histopathological responses to platelet activating factor (Paf-acether) in the guinea-pig.
    Dewar A; Archer CB; Paul W; Page CP; MacDonald DM; Morley J
    J Pathol; 1984 Sep; 144(1):25-34. PubMed ID: 6481526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of platelet-activating factor on hypothalamic and hypophyseal pro-opiomelanocortin-related peptides and hypothalamo-pituitary-adrenal axis in the rat.
    Blasquez C; Jégou S; Delarue C; Delbende C; Bunel DT; Braquet P; Vaudry H
    Eur J Pharmacol; 1990 Feb; 177(3):145-53. PubMed ID: 2155805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of platelet-activating factor on the responsiveness of the human nasal airway.
    Austin CE; Foreman JC
    Br J Pharmacol; 1993 Sep; 110(1):113-8. PubMed ID: 8220870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucosal dysfunction and damage induced by platelet activating factor (PAF).
    Ganbo T; Hisamatsu K
    Acta Otolaryngol; 1990; 110(5-6):427-36. PubMed ID: 2284918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biologic properties of LTB4 and paf-acether in vivo in human skin.
    Michel L; Mencia-Huerta JM; Benveniste J; Dubertret L
    J Invest Dermatol; 1987 Jun; 88(6):675-81. PubMed ID: 3035030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human platelet aggregation and release reaction induced by platelet activating factor (PAF-acether)--effects of acetylsalicylic acid and external ionized calcium.
    Cattaneo M; Canciani MT; Mannucci PM
    Thromb Haemost; 1985 Apr; 53(2):221-4. PubMed ID: 3927505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tanakan inhibits platelet-activating-factor-induced platelet aggregation in healthy male volunteers.
    Guinot P; Caffrey E; Lambe R; Darragh A
    Haemostasis; 1989; 19(4):219-23. PubMed ID: 2807039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of topical treatment with H1 and H2 antagonists on clinical symptoms and nasal vascular reactions in patients with allergic rhinitis.
    Holmberg K; Pipkorn U; Bake B; Blychert LO
    Allergy; 1989 May; 44(4):281-7. PubMed ID: 2567579
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Triggering by Paf-acether and adrenaline of cyclo-oxygenase-independent platelet aggregation.
    Fouque F; Vargaftig BB
    Br J Pharmacol; 1984 Nov; 83(3):625-33. PubMed ID: 6439269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammatory characteristics of platelet activating factor (PAF-acether) in human skin.
    Archer CB; Page CP; Paul W; Morley J; MacDonald DM
    Br J Dermatol; 1984 Jan; 110(1):45-50. PubMed ID: 6581831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic actions of PAF-acether and sodium arachidonate in human platelet aggregation. 1. Studies in normal human platelet rich plasma.
    Altman R; Scazziota A; Rouvier J; Cacchione R
    Thromb Res; 1986 Jul; 43(1):103-11. PubMed ID: 3014677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reflex activation in allergen-induced nasal mucosal vascular reactions.
    Holmberg K; Bake B; Pipkorn U
    Acta Otolaryngol; 1989; 108(1-2):130-5. PubMed ID: 2763831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.